Our latest production release includes improvements to the consumer booking process, medical CSV...
Feature update - November 2023
HL7 laboratory imports
Exciting progress is being made in the development of dynamic reference ranges and we will be providing further progress updates over the coming weeks.
To align with this advancement, manual correction of client sex at birth or date of birth on HL7 messages will no longer be possible.
In the event that a result fails to import due to a discrepancy in date or birth or sex at birth, providers will need to reach out to the lab to correct the details and resend the message.
Gender to sex at birth
In order to accurately capture the biological characteristics that impact medical data interpretation, we will be replacing the Gender field with Sex at birth across the platform in the next release later this week.
Our medical team have developed an iron studies module which will replace the existing haemochromatosis module. Our team will be reaching out to our customers who are currently using haemochromatosis to provide them with personalised guidance on how to smoothly transition their existing products and medicals.
The iron studies module will be available to all customers from Wednesday 15th November 2023.
Phone call required
Phone call alerts will convey the same information but have been improved to enhance visibility. This includes displaying a phone call icon beside individual results and their associated health category.
When failed HL7 imports are resolved, a strike through will now be automatically applied on the notifications list, removing the need to manually mark as resolved.
Just to note when adding atrial fibrillation to a product, we recommend also adding the heart rate health category. This will provide individualised interpretative output for heart rate rather than a more limited interpretation for atrial fibrillation alone.